Mankind Pharma to Acquire 70% Stake in Belgian CAR-T Cancer Therapy Developer for €48 Million

ACTx is developing a new generation of engineered CAR-T cells designed to improve their ability to identify cancer cells, sustain anti-tumour activity and overcome biological mechanisms that allow tumours to resist treatment.
Read the full report on Dharmakshethra - India Unabridged
Story file
- Section
- Health
- Topics
- Economy & RBI, Health alerts, Cars & bikes
- First reported by
- Dharmakshethra - India Unabridged
- Reporter
- kautilya
- Published
- Saturday, 17 October 2026, 6:30 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Dharmakshethra - India Unabridged with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.



